美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

PagerDuty, Inc.

6.31

-0.0200-0.32%

盘后：6.430.1200+1.90%19:11 EDT

成交量：236.95万

成交额：1,502.02万

市值：5.36亿

市盈率：3.37

高：6.52

开：6.27

低：6.23

收：6.33

52周最高：19.68

52周最低：6.15

股本：8,497.95万

流通股本：8,062.89万

量比：0.74

换手率：2.94%

股息：- -

股息率：- -

每股收益(TTM):1.87

每股收益(LYR):1.87

净资产收益率：82.50%

总资产收益率：0.48%

市净率：2.11

市盈率(LYR):3.37

数据加载中...

总览公司新闻资讯公告

PagerDuty- 11月22日，Owen Howard Wilson 通知其计划在公司任命继任者后退休，担任首席财务官

复星医药(600196.SH)：斯鲁利单抗纳入突破性治疗药物程序全球范围内尚无靶向PD-1的单抗药品获批用于胃癌新辅助/辅助治疗

招商证券：首予三生制药（01530）“强烈推荐”评级 PD-1/VEGF双抗引领价值重估

智通财经网

泽璟制药(688266.SH)：注射用ZG006与PD-1/PD-L1免疫检查点抑制剂及化疗(依托泊苷/卡铂)联用获得药物临床试验批准

复宏汉霖PD-L1 ADC肺癌新药发布关键数据，CEO朱俊：定位PD-1 联用的super ADC

PD-L1 ADC肺癌数据积极复宏汉霖HLX43迎关键节点与资金考验

每日经济新闻

基石药业-B(02616)宣布CS2009(PD-1/VEGF/CTLA-4三特异性抗体)Ⅱ期临床试验联合疗法IND在中国获批，深入探索三抗治疗潜力

三生国健(688336.SH)：辉瑞在某网站上登记PD-1/VEGF双抗PF-08634404(SSGJ-707)的两项全球III期临床试验其最终付款尚存在不确定性

和誉-B(02256)完成口服小分子PD-L1抑制剂ABSK043联合戈来雷塞治疗NSCLC II期临床首例患者给药

PD-1 plus 全景扫描：从经典双免到多维进击

丁香园肿瘤时间

默沙东PD-1+ADC杀疯了

PD-(L)1/VEGF赛道攻坚，依沃西冲击首个海外适应症

21世纪经济报道

【券商聚焦】交银国际维持康方生物(09926)买入评级指依沃西较PD-1显著提升一线肺鳞癌PFS

复宏汉霖PD-L1 ADC HLX43获美国FDA孤儿药资格认定

南方财经网

港股异动 | 基石药业-B(02616)涨超3% 将于ESMO大会上公布PD-1/VEGF/CTLA-4三抗I期剂量递增临床数据

基石药业-B(02616)将公布PD-1/VEGF/CTLA-4三抗I期剂量递增临床数据和ROR1 ADC最新研究设计

山西证券：首予三生制药(01530)“买入-B”评级 PD-1/VEGF双抗是潜在的肿瘤基石药物

天风证券：维持和誉-B(02256)“买入”评级口服PD-L1与多药联用布局

Pagerduty, Inc.盘中异动急速拉升5.05%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PD/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","market":"US","secType":"STK","nameCN":"PagerDuty, Inc.","latestPrice":6.31,"timestamp":1774555200000,"preClose":6.33,"halted":0,"volume":2369453,"hourTrading":{"tag":"盘后","latestPrice":6.43,"preClose":6.31,"latestTime":"19:11 EDT","volume":78084,"amount":492728.09,"timestamp":1774566696046,"change":0.12,"changeRate":0.019017,"amplitude":0.019017},"delay":0,"changeRate":-0.003159557661927403,"floatShares":80628900,"shares":84979482,"eps":1.87,"marketStatus":"未开盘","change":-0.02,"latestTime":"03-26 16:00:00 EDT","open":6.27,"high":6.52,"low":6.225,"amount":15020238.845219798,"amplitude":0.046603,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.87,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774598400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1554955200000,"exchange":"NYSE","adjPreClose":6.33,"preHourTrading":{"tag":"盘前","latestPrice":6.29,"preClose":6.33,"latestTime":"09:26 EDT","volume":655,"amount":4099.2207565,"timestamp":1774531575608,"change":-0.04,"changeRate":-0.006319,"amplitude":0.03387},"postHourTrading":{"tag":"盘后","latestPrice":6.43,"preClose":6.31,"latestTime":"19:11 EDT","volume":78084,"amount":492728.09,"timestamp":1774566696046,"change":0.12,"changeRate":0.019017,"amplitude":0.019017},"volumeRatio":0.741149,"impliedVol":1.0083,"impliedVolPercentile":0.9482},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","floatShares":80628900,"roa":"0.48%","roe":"82.50%","lyrEps":1.87,"volumeRatio":0.741149,"shares":84979482,"dividePrice":0,"high":6.52,"amplitude":0.046603,"preClose":6.33,"low":6.225,"week52Low":6.15,"pbRate":"2.11","psRate":"1.09","week52High":19.68,"institutionHeld":0,"latestPrice":6.31,"eps":1.87,"divideRate":0,"volume":2369453,"delay":0,"ttmEps":1.87,"open":6.27,"prevYearClose":13.11,"prevWeekClose":6.92,"prevMonthClose":7.06,"prevQuarterClose":13.11,"fiveDayClose":6.9,"twentyDayClose":7.08,"sixtyDayClose":13.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-12","symbol":"PD","fiscalQuarterEnding":"2026/01","expectedEps":0.04,"name":null,"time":"盘后","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-11-25","symbol":"PD","fiscalQuarterEnding":"2025/10","expectedEps":0.02,"name":null,"time":"盘后","type":"earning","dateTimestamp":1764046800000,"reportTimeType":"post","actualEps":0.15},{"date":"2025-09-03","symbol":"PD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/07","expectedEps":-0.02,"defaultRemindTime":1756929600000,"name":null,"time":"盘后","dateTimestamp":1756872000000,"actualEps":null},{"market":"US","date":"2025-05-29","symbol":"PD","fiscalQuarterEnding":"2025/04","expectedEps":-0.06,"name":null,"time":"盘后","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-03-13","symbol":"PD","fiscalQuarterEnding":"2025/01","expectedEps":-0.12,"name":null,"time":"盘后","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.5556,"sell":0.1111,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5556,"analysts":9,"updateTime":1773460800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PD","date":"2026-03-25","current":3.374332,"percent":0.93372,"low":-115.332138,"twenty":-37.803912,"median":-23.161363,"eighty":-19.358818,"high":9.29824,"avg":-28.496754,"sd":21.328615,"marketCap":549159228},"quantilePoints":[{"date":"2021-03-26","current":-46.372989,"twenty":-68.782324,"median":-45.852876,"eighty":-38.706425,"marketCap":3195238028},{"date":"2021-04-01","current":-49.627656,"twenty":-68.703922,"median":-45.852876,"eighty":-38.74149,"marketCap":3419494401},{"date":"2021-04-09","current":-50.688437,"twenty":-68.634603,"median":-45.95625,"eighty":-38.792193,"marketCap":3492585367},{"date":"2021-04-16","current":-50.965686,"twenty":-68.620415,"median":-46.098464,"eighty":-38.810779,"marketCap":3511688688},{"date":"2021-04-23","current":-50.965686,"twenty":-68.551655,"median":-46.177802,"eighty":-38.849388,"marketCap":3511688688},{"date":"2021-04-30","current":-51.182664,"twenty":-68.073194,"median":-46.296231,"eighty":-38.932876,"marketCap":3526639113},{"date":"2021-05-07","current":-45.52431,"twenty":-67.425697,"median":-46.35136,"eighty":-39.005886,"marketCap":3136761501},{"date":"2021-05-14","current":-42.286432,"twenty":-67.150653,"median":-46.187891,"eighty":-39.046881,"marketCap":2913662055},{"date":"2021-05-21","current":-44.081211,"twenty":-66.824039,"median":-46.121291,"eighty":-39.054259,"marketCap":3037327665},{"date":"2021-05-28","current":-49.295769,"twenty":-66.574781,"median":-46.172553,"eighty":-39.081958,"marketCap":3396626399},{"date":"2021-06-04","current":-36.968776,"twenty":-66.216652,"median":-46.172553,"eighty":-39.072116,"marketCap":2957576028},{"date":"2021-06-11","current":-42.279901,"twenty":-66.096321,"median":-46.075636,"eighty":-39.072116,"marketCap":3382476656},{"date":"2021-06-18","current":-45.709132,"twenty":-65.976077,"median":-45.923735,"eighty":-39.125091,"marketCap":3656821944},{"date":"2021-06-25","current":-47.162372,"twenty":-65.815901,"median":-46.067026,"eighty":-39.183405,"marketCap":3773084124},{"date":"2021-07-02","current":-44.130431,"twenty":-65.216755,"median":-46.011638,"eighty":-39.205083,"marketCap":3530522741},{"date":"2021-07-09","current":-45.834591,"twenty":-65.021933,"median":-45.883552,"eighty":-39.229781,"marketCap":3666858967},{"date":"2021-07-16","current":-40.199362,"twenty":-64.900098,"median":-45.829869,"eighty":-39.313533,"marketCap":3216029363},{"date":"2021-07-23","current":-43.325398,"twenty":-64.76408,"median":-45.766347,"eighty":-39.330284,"marketCap":3466118512},{"date":"2021-07-30","current":-42.436726,"twenty":-64.636745,"median":-45.712576,"eighty":-39.369202,"marketCap":3395022935},{"date":"2021-08-06","current":-44.33953,"twenty":-64.491902,"median":-45.685037,"eighty":-39.631794,"marketCap":3547251112},{"date":"2021-08-13","current":-42.269446,"twenty":-64.377301,"median":-45.655572,"eighty":-39.648544,"marketCap":3381640238},{"date":"2021-08-20","current":-40.387552,"twenty":-64.32,"median":-45.516041,"eighty":-39.732297,"marketCap":3231084897},{"date":"2021-08-27","current":-43.743597,"twenty":-64.248374,"median":-45.492434,"eighty":-39.784241,"marketCap":3499575255},{"date":"2021-09-03","current":-42.390054,"twenty":-64.090797,"median":-45.440934,"eighty":-39.784241,"marketCap":4025995391},{"date":"2021-09-10","current":-39.410762,"twenty":-63.838675,"median":-45.357157,"eighty":-39.773852,"marketCap":3743037083},{"date":"2021-09-17","current":-42.488469,"twenty":-63.43184,"median":-45.291593,"eighty":-39.773852,"marketCap":4035342362},{"date":"2021-09-24","current":-41.531159,"twenty":-63.322968,"median":-45.131991,"eighty":-39.806871,"marketCap":3944421825},{"date":"2021-10-01","current":-37.845067,"twenty":-63.294318,"median":-44.969953,"eighty":-39.673042,"marketCap":3594335269},{"date":"2021-10-08","current":-35.304169,"twenty":-63.234694,"median":-44.895964,"eighty":-39.361418,"marketCap":3353013468},{"date":"2021-10-15","current":-36.968279,"twenty":-62.977151,"median":-44.757709,"eighty":-39.195032,"marketCap":3511062253},{"date":"2021-10-22","current":-37.567716,"twenty":-62.673,"median":-44.689179,"eighty":-39.048237,"marketCap":3567993805},{"date":"2021-10-29","current":-37.352992,"twenty":-62.144822,"median":-44.662724,"eighty":-38.884343,"marketCap":3547600413},{"date":"2021-11-05","current":-38.927633,"twenty":-61.970673,"median":-44.622066,"eighty":-38.780249,"marketCap":3697151952},{"date":"2021-11-12","current":-37.684024,"twenty":-61.914834,"median":-44.517265,"eighty":-38.690435,"marketCap":3579040225},{"date":"2021-11-19","current":-34.892615,"twenty":-61.891288,"median":-44.350719,"eighty":-38.663132,"marketCap":3313926135},{"date":"2021-11-26","current":-33.094304,"twenty":-61.87812,"median":-44.340807,"eighty":-38.647574,"marketCap":3143131480},{"date":"2021-12-03","current":-27.717262,"twenty":-61.851785,"median":-44.310434,"eighty":-38.490518,"marketCap":2632446965},{"date":"2021-12-10","current":-29.437491,"twenty":-61.634212,"median":-44.193031,"eighty":-38.342002,"marketCap":2964590848},{"date":"2021-12-17","current":-29.446029,"twenty":-61.446371,"median":-44.130431,"eighty":-38.122419,"marketCap":2965450648},{"date":"2021-12-23","current":-30.863263,"twenty":-61.141525,"median":-44.120926,"eighty":-37.910083,"marketCap":3108177469},{"date":"2021-12-31","current":-29.668005,"twenty":-60.679678,"median":-44.096614,"eighty":-37.767931,"marketCap":2987805451},{"date":"2022-01-07","current":-27.243339,"twenty":-60.561077,"median":-44.020576,"eighty":-37.685906,"marketCap":2743622214},{"date":"2022-01-14","current":-26.466422,"twenty":-60.402519,"median":-43.931787,"eighty":-37.609143,"marketCap":2665380403},{"date":"2022-01-21","current":-25.715117,"twenty":-60.229637,"median":-43.82863,"eighty":-37.535067,"marketCap":2589717991},{"date":"2022-01-28","current":-27.448241,"twenty":-60.179262,"median":-43.748751,"eighty":-37.457573,"marketCap":2764257417},{"date":"2022-02-04","current":-27.106738,"twenty":-60.125395,"median":-43.643849,"eighty":-37.310047,"marketCap":2729865412},{"date":"2022-02-11","current":-28.728874,"twenty":-59.884929,"median":-43.550718,"eighty":-37.143446,"marketCap":2893227437},{"date":"2022-02-18","current":-27.106738,"twenty":-59.724487,"median":-43.492185,"eighty":-36.968378,"marketCap":2729865412},{"date":"2022-02-25","current":-28.071482,"twenty":-59.678646,"median":-43.437917,"eighty":-36.905651,"marketCap":2827022827},{"date":"2022-03-04","current":-25.322389,"twenty":-59.583656,"median":-43.360924,"eighty":-36.834452,"marketCap":2550167185},{"date":"2022-03-11","current":-22.70136,"twenty":-59.306192,"median":-43.319423,"eighty":-36.766338,"marketCap":2286208545},{"date":"2022-03-18","current":-28.291592,"twenty":-59.172166,"median":-43.295217,"eighty":-36.444632,"marketCap":3040073042},{"date":"2022-03-25","current":-28.785804,"twenty":-59.048339,"median":-43.241759,"eighty":-36.064649,"marketCap":3093178556},{"date":"2022-04-01","current":-27.724464,"twenty":-59.048339,"median":-43.1764,"eighty":-35.678665,"marketCap":2979132288},{"date":"2022-04-08","current":-25.415442,"twenty":-58.958192,"median":-43.086807,"eighty":-35.293402,"marketCap":2731016361},{"date":"2022-04-14","current":-26.428171,"twenty":-58.866018,"median":-43.039133,"eighty":-34.945236,"marketCap":2839839136},{"date":"2022-04-22","current":-23.843687,"twenty":-58.778063,"median":-42.940117,"eighty":-34.48789,"marketCap":2562123414},{"date":"2022-04-29","current":-23.14693,"twenty":-58.704534,"median":-42.888728,"eighty":-33.407653,"marketCap":2487253345},{"date":"2022-05-06","current":-21.039181,"twenty":-58.614907,"median":-42.82356,"eighty":-33.196501,"marketCap":2260765197},{"date":"2022-05-13","current":-21.537198,"twenty":-58.533862,"median":-42.744231,"eighty":-33.138326,"marketCap":2314279623},{"date":"2022-05-20","current":-19.528801,"twenty":-58.506847,"median":-42.67719,"eighty":-32.784627,"marketCap":2098467346},{"date":"2022-05-27","current":-21.055509,"twenty":-58.47232,"median":-42.506172,"eighty":-32.56425,"marketCap":2262519768},{"date":"2022-06-03","current":-19.41561,"twenty":-58.365647,"median":-42.492303,"eighty":-32.253988,"marketCap":2285547362},{"date":"2022-06-10","current":-18.661968,"twenty":-58.119439,"median":-42.449993,"eighty":-31.627913,"marketCap":2196830881},{"date":"2022-06-17","current":-17.871017,"twenty":-57.794408,"median":-42.412967,"eighty":-30.853018,"marketCap":2103722495},{"date":"2022-06-24","current":-21.251213,"twenty":-57.545961,"median":-42.37641,"eighty":-30.527663,"marketCap":2501629088},{"date":"2022-07-01","current":-18.975364,"twenty":-57.27835,"median":-42.328632,"eighty":-30.205871,"marketCap":2233722883},{"date":"2022-07-08","current":-20.758734,"twenty":-57.119373,"median":-42.300639,"eighty":-29.937792,"marketCap":2443655942},{"date":"2022-07-15","current":-19.512613,"twenty":-57.022546,"median":-42.274674,"eighty":-29.686169,"marketCap":2296966315},{"date":"2022-07-22","current":-19.751391,"twenty":-56.538634,"median":-42.258991,"eighty":-29.576542,"marketCap":2325074507},{"date":"2022-07-29","current":-19.348454,"twenty":-55.37095,"median":-42.1379,"eighty":-29.489533,"marketCap":2277641933},{"date":"2022-08-05","current":-21.340755,"twenty":-54.581356,"median":-41.999461,"eighty":-29.249821,"marketCap":2512169660},{"date":"2022-08-12","current":-21.370602,"twenty":-54.282209,"median":-41.907002,"eighty":-28.899625,"marketCap":2515683184},{"date":"2022-08-19","current":-19.214141,"twenty":-54.164004,"median":-41.742363,"eighty":-28.761236,"marketCap":2261831075},{"date":"2022-08-26","current":-19.318607,"twenty":-54.013801,"median":-41.687142,"eighty":-28.490216,"marketCap":2274128409},{"date":"2022-09-02","current":-16.562766,"twenty":-53.825684,"median":-41.612639,"eighty":-28.401837,"marketCap":2096100841},{"date":"2022-09-09","current":-17.753369,"twenty":-53.67791,"median":-41.5952,"eighty":-28.368118,"marketCap":2246777593},{"date":"2022-09-16","current":-16.597991,"twenty":-53.584381,"median":-41.569297,"eighty":-28.257217,"marketCap":2100558733},{"date":"2022-09-23","current":-15.858267,"twenty":-53.533149,"median":-41.530643,"eighty":-28.105632,"marketCap":2006943000},{"date":"2022-09-30","current":-16.252786,"twenty":-53.345477,"median":-41.466004,"eighty":-27.873415,"marketCap":2056871391},{"date":"2022-10-07","current":-16.182337,"twenty":-53.110426,"median":-41.390601,"eighty":-27.717262,"marketCap":2047955607},{"date":"2022-10-14","current":-14.646529,"twenty":-52.79331,"median":-41.34773,"eighty":-27.636067,"marketCap":1853591514},{"date":"2022-10-21","current":-16.485271,"twenty":-52.578578,"median":-41.307589,"eighty":-27.328715,"marketCap":2086293479},{"date":"2022-10-28","current":-17.922449,"twenty":-52.484531,"median":-41.281723,"eighty":-27.012825,"marketCap":2268175475},{"date":"2022-11-04","current":-14.604259,"twenty":-52.445692,"median":-41.223096,"eighty":-26.683037,"marketCap":1848242043},{"date":"2022-11-11","current":-17.35885,"twenty":-52.440537,"median":-41.165581,"eighty":-26.46868,"marketCap":2196849202},{"date":"2022-11-18","current":-15.442613,"twenty":-51.97825,"median":-41.046215,"eighty":-26.415612,"marketCap":1954339874},{"date":"2022-11-25","current":-15.379208,"twenty":-51.971496,"median":-40.952393,"eighty":-26.24103,"marketCap":1946315669},{"date":"2022-12-02","current":-16.042428,"twenty":-51.941247,"median":-40.886211,"eighty":-26.002015,"marketCap":2129728606},{"date":"2022-12-09","current":-16.110204,"twenty":-51.872986,"median":-40.837833,"eighty":-25.713912,"marketCap":2138726192},{"date":"2022-12-16","current":-18.028246,"twenty":-51.7604,"median":-40.772608,"eighty":-25.598799,"marketCap":2393357876},{"date":"2022-12-23","current":-17.994359,"twenty":-51.70784,"median":-40.745253,"eighty":-25.338499,"marketCap":2388859083},{"date":"2022-12-30","current":-18.001136,"twenty":-51.570726,"median":-40.701201,"eighty":-25.184081,"marketCap":2389758841},{"date":"2023-01-06","current":-16.049206,"twenty":-51.363479,"median":-40.623172,"eighty":-24.85486,"marketCap":2130628364},{"date":"2023-01-13","current":-18.78733,"twenty":-51.102161,"median":-40.574619,"eighty":-24.231092,"marketCap":2494130839},{"date":"2023-01-20","current":-18.882216,"twenty":-50.978262,"median":-40.523325,"eighty":-23.99114,"marketCap":2506727459},{"date":"2023-01-27","current":-19.925957,"twenty":-50.965686,"median":-40.469321,"eighty":-23.312385,"marketCap":2645290284},{"date":"2023-02-03","current":-21.220466,"twenty":-50.951221,"median":-40.311267,"eighty":-22.57339,"marketCap":2817144176},{"date":"2023-02-10","current":-19.627745,"twenty":-50.890949,"median":-40.250171,"eighty":-21.596594,"marketCap":2605700905},{"date":"2023-02-17","current":-20.664708,"twenty":-50.876484,"median":-40.190227,"eighty":-21.430411,"marketCap":2743363971},{"date":"2023-02-24","current":-19.485417,"twenty":-50.857197,"median":-40.120759,"eighty":-21.251213,"marketCap":2586805975},{"date":"2023-03-03","current":-20.834146,"twenty":-50.688437,"median":-40.045986,"eighty":-21.055509,"marketCap":2765857936},{"date":"2023-03-10","current":-18.204462,"twenty":-50.646894,"median":-39.953806,"eighty":-20.967665,"marketCap":2416751599},{"date":"2023-03-17","current":-22.814647,"twenty":-50.628165,"median":-39.81605,"eighty":-20.881589,"marketCap":2929925462},{"date":"2023-03-24","current":-22.508745,"twenty":-50.547877,"median":-39.758269,"eighty":-20.937818,"marketCap":2890640524},{"date":"2023-03-31","current":-24.884826,"twenty":-50.538628,"median":-39.648544,"eighty":-20.967665,"marketCap":3195783993},{"date":"2023-04-06","current":-22.608341,"twenty":-50.398102,"median":-39.410762,"eighty":-20.985573,"marketCap":2903430969},{"date":"2023-04-14","current":-23.753697,"twenty":-50.260054,"median":-39.321908,"eighty":-21.029355,"marketCap":3050521084},{"date":"2023-04-21","current":-24.273021,"twenty":-50.211876,"median":-39.198908,"eighty":-21.041663,"marketCap":3117214118},{"date":"2023-04-28","current":-22.053448,"twenty":-50.10983,"median":-39.086878,"eighty":-21.052864,"marketCap":2832169920},{"date":"2023-05-05","current":-20.085339,"twenty":-50.030853,"median":-39.045525,"eighty":-21.029355,"marketCap":2579419472},{"date":"2023-05-12","current":-21.254175,"twenty":-50.011348,"median":-38.97946,"eighty":-20.981096,"marketCap":2729524925},{"date":"2023-05-19","current":-21.074906,"twenty":-49.936988,"median":-38.858126,"eighty":-20.935287,"marketCap":2706502616},{"date":"2023-05-26","current":-18.98821,"twenty":-49.739821,"median":-38.781427,"eighty":-20.865452,"marketCap":2438522942},{"date":"2023-06-02","current":-23.7011,"twenty":-49.634889,"median":-38.748697,"eighty":-20.83367,"marketCap":2555476271},{"date":"2023-06-09","current":-19.16437,"twenty":-49.587066,"median":-38.685442,"eighty":-20.780404,"marketCap":2066321490},{"date":"2023-06-16","current":-19.591955,"twenty":-49.518553,"median":-38.668128,"eighty":-20.758997,"marketCap":2112424156},{"date":"2023-06-23","current":-18.642716,"twenty":-49.490829,"median":-38.652026,"eighty":-20.740419,"marketCap":2010076237},{"date":"2023-06-30","current":-18.830853,"twenty":-49.425691,"median":-38.650282,"eighty":-20.728887,"marketCap":2030361410},{"date":"2023-07-07","current":-18.753888,"twenty":-49.321753,"median":-38.534252,"eighty":-20.640309,"marketCap":2022062930},{"date":"2023-07-14","current":-21.12271,"twenty":-49.135663,"median":-38.486364,"eighty":-20.586625,"marketCap":2277471700},{"date":"2023-07-21","current":-20.626711,"twenty":-49.077653,"median":-38.375503,"eighty":-20.595005,"marketCap":2223992607},{"date":"2023-07-28","current":-21.105606,"twenty":-49.061015,"median":-38.330676,"eighty":-20.595005,"marketCap":2275627593},{"date":"2023-08-04","current":-20.883262,"twenty":-49.007339,"median":-38.158206,"eighty":-20.613914,"marketCap":2251654207},{"date":"2023-08-11","current":-20.549746,"twenty":-48.954208,"median":-37.988814,"eighty":-20.586625,"marketCap":2215694127},{"date":"2023-08-18","current":-20.01954,"twenty":-48.941266,"median":-37.845067,"eighty":-20.541194,"marketCap":2158526822},{"date":"2023-08-25","current":-20.66947,"twenty":-48.894876,"median":-37.770349,"eighty":-20.506987,"marketCap":2228602874},{"date":"2023-09-01","current":-25.511357,"twenty":-48.832826,"median":-37.755599,"eighty":-20.541194,"marketCap":2375209352},{"date":"2023-09-07","current":-24.043412,"twenty":-48.807682,"median":-37.686377,"eighty":-20.560008,"marketCap":2238537799},{"date":"2023-09-14","current":-23.412009,"twenty":-48.750972,"median":-37.671633,"eighty":-20.577111,"marketCap":2179751687},{"date":"2023-09-22","current":-22.590183,"twenty":-48.595885,"median":-37.578261,"eighty":-20.58462,"marketCap":2103236431},{"date":"2023-09-28","current":-22.048981,"twenty":-48.583225,"median":-37.547623,"eighty":-20.587293,"marketCap":2052848336},{"date":"2023-10-05","current":-21.978825,"twenty":-48.576545,"median":-37.531928,"eighty":-20.595005,"marketCap":2046316545},{"date":"2023-10-11","current":-21.497757,"twenty":-48.562801,"median":-37.500901,"eighty":-20.605423,"marketCap":2001527127},{"date":"2023-10-20","current":-20.345196,"twenty":-48.534663,"median":-37.448341,"eighty":-20.589221,"marketCap":1894219146},{"date":"2023-10-27","current":-19.894194,"twenty":-48.514606,"median":-37.410785,"eighty":-20.580532,"marketCap":1852229066},{"date":"2023-11-03","current":-20.485508,"twenty":-48.433814,"median":-37.299311,"eighty":-20.506205,"marketCap":1907282726},{"date":"2023-11-10","current":-20.746087,"twenty":-48.370598,"median":-37.219715,"eighty":-20.506987,"marketCap":1931543661},{"date":"2023-11-17","current":-21.217133,"twenty":-48.32991,"median":-37.120374,"eighty":-20.524091,"marketCap":1975399966},{"date":"2023-11-24","current":-21.858558,"twenty":-48.320008,"median":-37.057747,"eighty":-20.549746,"marketCap":2035119191},{"date":"2023-11-30","current":-22.048981,"twenty":-48.252059,"median":-36.968279,"eighty":-20.57027,"marketCap":2052848336},{"date":"2023-12-07","current":-26.625426,"twenty":-48.121131,"median":-36.925787,"eighty":-20.578821,"marketCap":2015198621},{"date":"2023-12-15","current":-28.276615,"twenty":-48.00719,"median":-36.911135,"eighty":-20.582242,"marketCap":2140172179},{"date":"2024-01-05","current":-26.103359,"twenty":-47.918569,"median":-36.904212,"eighty":-20.585288,"marketCap":1975684923},{"date":"2024-01-12","current":-31.117632,"twenty":-47.865829,"median":-36.842529,"eighty":-20.591149,"marketCap":2355200212},{"date":"2024-01-19","current":-31.627558,"twenty":-47.844972,"median":-36.829603,"eighty":-20.601178,"marketCap":2393794988},{"date":"2024-01-26","current":-29.053645,"twenty":-47.78321,"median":-36.766338,"eighty":-20.619869,"marketCap":2198983265},{"date":"2024-02-02","current":-29.32075,"twenty":-47.731847,"median":-36.504107,"eighty":-20.628421,"marketCap":2219199576},{"date":"2024-02-09","current":-29.393596,"twenty":-47.672575,"median":-36.388531,"eighty":-20.635263,"marketCap":2224713115},{"date":"2024-02-16","current":-29.733547,"twenty":-47.618326,"median":-36.095963,"eighty":-20.635379,"marketCap":2250442965},{"date":"2024-02-23","current":-28.10664,"twenty":-47.602066,"median":-35.89466,"eighty":-20.635842,"marketCap":2127307254},{"date":"2024-03-01","current":-29.332891,"twenty":-47.570415,"median":-35.678665,"eighty":-20.651153,"marketCap":2220118499},{"date":"2024-03-08","current":-29.55143,"twenty":-47.518149,"median":-35.35785,"eighty":-20.660918,"marketCap":2236659117},{"date":"2024-03-15","current":-26.009561,"twenty":-47.49129,"median":-35.24315,"eighty":-20.664708,"marketCap":2126463652},{"date":"2024-03-22","current":-25.786705,"twenty":-47.380514,"median":-34.925503,"eighty":-20.66947,"marketCap":2108243640},{"date":"2024-03-28","current":-24.935846,"twenty":-47.342533,"median":-34.589879,"eighty":-20.66947,"marketCap":2038679948},{"date":"2024-04-05","current":-25.071983,"twenty":-47.312176,"median":-34.414946,"eighty":-20.689994,"marketCap":2049810139},{"date":"2024-04-12","current":-25.888808,"twenty":-47.269427,"median":-33.423363,"eighty":-20.697474,"marketCap":2116591283},{"date":"2024-04-19","current":-23.631195,"twenty":-47.158961,"median":-33.184171,"eighty":-20.697474,"marketCap":1932015619},{"date":"2024-04-26","current":-22.916473,"twenty":-46.951231,"median":-33.003753,"eighty":-20.698257,"marketCap":1873582118},{"date":"2024-05-03","current":-23.897861,"twenty":-46.656905,"median":-32.649248,"eighty":-20.698257,"marketCap":1953817432},{"date":"2024-05-10","current":-23.114516,"twenty":-46.598159,"median":-32.247909,"eighty":-20.698257,"marketCap":1889773514},{"date":"2024-05-17","current":-24.517522,"twenty":-46.43348,"median":-31.759443,"eighty":-20.698257,"marketCap":2004479038},{"date":"2024-05-24","current":-22.904066,"twenty":-46.181838,"median":-31.451512,"eighty":-20.698257,"marketCap":1872567685},{"date":"2024-05-31","current":-20.986625,"twenty":-46.068748,"median":-31.128449,"eighty":-20.698257,"marketCap":1715803469},{"date":"2024-06-07","current":-20.224161,"twenty":-45.830813,"median":-30.643949,"eighty":-20.66395,"marketCap":1892880316},{"date":"2024-06-14","current":-21.429439,"twenty":-45.725202,"median":-30.31849,"eighty":-20.645029,"marketCap":2005688335},{"date":"2024-06-21","current":-21.357939,"twenty":-45.671397,"median":-29.967092,"eighty":-20.641966,"marketCap":1998996334},{"date":"2024-06-28","current":-23.247571,"twenty":-45.51108,"median":-29.932669,"eighty":-20.635726,"marketCap":2175856364},{"date":"2024-07-05","current":-22.542789,"twenty":-45.42729,"median":-29.794252,"eighty":-20.635726,"marketCap":2109892353},{"date":"2024-07-12","current":-21.439653,"twenty":-45.27192,"median":-29.668005,"eighty":-20.635726,"marketCap":2006644335},{"date":"2024-07-15","current":-21.807365,"twenty":-45.165128,"median":-29.6527,"eighty":-20.635726,"marketCap":2041060341},{"date":"2024-08-02","current":-20.438659,"twenty":-44.67116,"median":-29.473821,"eighty":-20.619869,"marketCap":1912956320},{"date":"2024-08-09","current":-18.937169,"twenty":-44.592228,"median":-29.326821,"eighty":-20.554877,"marketCap":1772424296},{"date":"2024-08-16","current":-19.846234,"twenty":-44.342086,"median":-29.065787,"eighty":-20.488395,"marketCap":1857508310},{"date":"2024-08-23","current":-19.366166,"twenty":-44.293477,"median":-28.968658,"eighty":-20.439367,"marketCap":1812576303},{"date":"2024-08-30","current":-20.193518,"twenty":-44.126836,"median":-28.878841,"eighty":-20.396729,"marketCap":1890012316},{"date":"2024-09-06","current":-20.851386,"twenty":-44.070828,"median":-28.815003,"eighty":-20.350301,"marketCap":1731811836},{"date":"2024-09-13","current":-19.495653,"twenty":-43.902513,"median":-28.750118,"eighty":-20.261779,"marketCap":1619211496},{"date":"2024-09-20","current":-20.358392,"twenty":-43.724824,"median":-28.493474,"eighty":-20.244564,"marketCap":1690866258},{"date":"2024-09-27","current":-20.324779,"twenty":-43.52784,"median":-28.425739,"eighty":-20.226358,"marketCap":1688074514},{"date":"2024-10-04","current":-19.753355,"twenty":-43.367535,"median":-28.373476,"eighty":-20.209123,"marketCap":1640614867},{"date":"2024-10-11","current":-20.30237,"twenty":-43.311657,"median":-28.264591,"eighty":-20.195561,"marketCap":1686213351},{"date":"2024-10-18","current":-21.030656,"twenty":-43.248031,"median":-28.136018,"eighty":-20.195561,"marketCap":1746701137},{"date":"2024-10-25","current":-20.078282,"twenty":-43.248031,"median":-28.049113,"eighty":-20.145499,"marketCap":1667601725},{"date":"2024-10-31","current":-20.649706,"twenty":-43.248031,"median":-27.765641,"eighty":-20.132647,"marketCap":1715061372},{"date":"2024-11-08","current":-22.688907,"twenty":-43.252213,"median":-27.636067,"eighty":-20.132233,"marketCap":1884427173},{"date":"2024-11-15","current":-21.960621,"twenty":-43.252213,"median":-27.448241,"eighty":-20.132233,"marketCap":1823939387},{"date":"2024-11-22","current":-22.229527,"twenty":-43.231304,"median":-27.106738,"eighty":-20.132233,"marketCap":1846273338},{"date":"2024-11-29","current":-25.707412,"twenty":-43.145724,"median":-26.876224,"eighty":-20.132233,"marketCap":1914893729},{"date":"2024-12-06","current":-25.40483,"twenty":-43.145724,"median":-26.625426,"eighty":-20.132233,"marketCap":1892354961},{"date":"2024-12-13","current":-24.521289,"twenty":-43.145724,"median":-26.466422,"eighty":-20.132233,"marketCap":1826541758},{"date":"2024-12-20","current":-22.572657,"twenty":-43.145724,"median":-26.327469,"eighty":-20.132233,"marketCap":1681392092},{"date":"2024-12-27","current":-22.173248,"twenty":-43.145724,"median":-26.203648,"eighty":-20.132233,"marketCap":1651640919},{"date":"2025-01-03","current":-21.785943,"twenty":-43.145724,"median":-26.12294,"eighty":-20.132233,"marketCap":1622791296},{"date":"2025-01-10","current":-21.434947,"twenty":-43.151859,"median":-25.994723,"eighty":-20.130744,"marketCap":1596646325},{"date":"2025-01-17","current":-22.584761,"twenty":-43.151859,"median":-25.832017,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-24","current":-22.584761,"twenty":-43.151859,"median":-25.722549,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-31","current":-22.330591,"twenty":-43.151859,"median":-25.688138,"eighty":-20.130744,"marketCap":1663361078},{"date":"2025-02-07","current":-23.032583,"twenty":-43.151859,"median":-25.544418,"eighty":-20.130744,"marketCap":1715651020},{"date":"2025-02-14","current":-23.601438,"twenty":-43.151859,"median":-25.410136,"eighty":-20.130744,"marketCap":1758023904},{"date":"2025-02-21","current":-22.149042,"twenty":-43.151859,"median":-25.353801,"eighty":-20.130744,"marketCap":1649837817},{"date":"2025-02-28","current":-21.229191,"twenty":-43.151859,"median":-25.248903,"eighty":-20.130744,"marketCap":1581319962},{"date":"2025-03-07","current":-20.902402,"twenty":-43.157994,"median":-25.114351,"eighty":-20.129255,"marketCap":1556978093},{"date":"2025-03-14","current":-25.841364,"twenty":-43.157994,"median":-25.015259,"eighty":-20.118618,"marketCap":1407320673},{"date":"2025-03-21","current":-31.526661,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1716941957},{"date":"2025-03-28","current":-31.810986,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1732426315},{"date":"2025-04-04","current":-28.415807,"twenty":-43.157994,"median":-25.140052,"eighty":-20.118618,"marketCap":1547524873},{"date":"2025-04-11","current":-25.672904,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1398146368},{"date":"2025-04-17","current":-25.238054,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1374464410},{"date":"2025-04-25","current":-26.22483,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1428204238},{"date":"2025-05-02","current":-26.007405,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1416363259},{"date":"2025-05-09","current":-26.208105,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1427293394},{"date":"2025-05-16","current":-28.064582,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1528397138},{"date":"2025-05-23","current":-26.826931,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1460994642},{"date":"2025-05-30","current":-40.212905,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1483896395},{"date":"2025-06-06","current":-38.417271,"twenty":-42.89345,"median":-25.054079,"eighty":-20.118618,"marketCap":1417635735},{"date":"2025-06-13","current":-37.443101,"twenty":-42.85482,"median":-25.054079,"eighty":-20.118618,"marketCap":1381687885},{"date":"2025-06-20","current":-35.644634,"twenty":-42.692819,"median":-25.045717,"eighty":-20.116377,"marketCap":1315322623},{"date":"2025-06-27","current":-37.218293,"twenty":-42.4845,"median":-25.045717,"eighty":-20.116377,"marketCap":1373392227},{"date":"2025-07-03","current":-39.940973,"twenty":-42.385562,"median":-25.045717,"eighty":-20.116377,"marketCap":1473861860},{"date":"2025-07-11","current":-39.516335,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1458192284},{"date":"2025-07-18","current":-36.593825,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1350348733},{"date":"2025-07-25","current":-36.743697,"twenty":-42.001222,"median":-25.045717,"eighty":-20.116377,"marketCap":1355879172},{"date":"2025-08-01","current":-40.265697,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1485844477},{"date":"2025-08-08","current":-38.941825,"twenty":-41.552011,"median":-25.045717,"eighty":-20.116377,"marketCap":1436992270},{"date":"2025-08-15","current":-38.667059,"twenty":-41.27534,"median":-25.045717,"eighty":-20.116377,"marketCap":1426853133},{"date":"2025-08-22","current":-39.441399,"twenty":-41.020287,"median":-25.045717,"eighty":-20.116377,"marketCap":1455427065},{"date":"2025-08-29","current":-42.263994,"twenty":-40.940123,"median":-25.045717,"eighty":-20.116377,"marketCap":1559583657},{"date":"2025-09-05","current":-111.301894,"twenty":-40.946258,"median":-25.037354,"eighty":-20.114136,"marketCap":1545092897},{"date":"2025-09-12","current":-111.369065,"twenty":-41.159237,"median":-25.045717,"eighty":-20.116377,"marketCap":1546025361},{"date":"2025-09-19","current":-110.361504,"twenty":-41.502219,"median":-25.045717,"eighty":-20.116377,"marketCap":1532038401},{"date":"2025-09-26","current":-108.816577,"twenty":-41.627318,"median":-25.045717,"eighty":-20.116377,"marketCap":1510591728},{"date":"2025-10-03","current":-110.630187,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1535768257},{"date":"2025-10-10","current":-109.824138,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1524578689},{"date":"2025-10-17","current":-105.659553,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1466765919},{"date":"2025-10-24","current":-107.540334,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1492874912},{"date":"2025-10-31","current":-105.793895,"twenty":-41.746269,"median":-25.045717,"eighty":-20.116377,"marketCap":1468630847},{"date":"2025-11-07","current":-101.562139,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1409885613},{"date":"2025-11-14","current":-104.719163,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1453711422},{"date":"2025-11-21","current":-98.740968,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1370722124},{"date":"2025-11-28","current":6.997444,"twenty":-41.746269,"median":-24.978468,"eighty":-20.091839,"marketCap":1065227860},{"date":"2025-12-05","current":7.219871,"twenty":-41.569584,"median":-24.845699,"eighty":-20.051536,"marketCap":1099088196},{"date":"2025-12-12","current":7.833049,"twenty":-41.149298,"median":-24.524361,"eighty":-20.010479,"marketCap":1192432905},{"date":"2025-12-19","current":7.79698,"twenty":-40.783904,"median":-24.456235,"eighty":-19.933106,"marketCap":1186942040},{"date":"2025-12-26","current":7.839061,"twenty":-40.638471,"median":-24.290539,"eighty":-19.921421,"marketCap":1193348049},{"date":"2026-01-02","current":7.881142,"twenty":-40.445544,"median":-24.213538,"eighty":-19.883804,"marketCap":1199754059},{"date":"2026-01-09","current":7.616633,"twenty":-40.245714,"median":-24.133436,"eighty":-19.850083,"marketCap":1159487714},{"date":"2026-01-16","current":7.105652,"twenty":-40.140803,"median":-24.036721,"eighty":-19.806911,"marketCap":1081700456},{"date":"2026-01-23","current":6.738947,"twenty":-40.000922,"median":-23.900481,"eighty":-19.757821,"marketCap":1025876659},{"date":"2026-01-30","current":6.318139,"twenty":-39.844633,"median":-23.836174,"eighty":-19.718173,"marketCap":961816564},{"date":"2026-02-06","current":4.749124,"twenty":-39.429144,"median":-23.74822,"eighty":-19.674843,"marketCap":722963925},{"date":"2026-02-13","current":4.075831,"twenty":-39.135469,"median":-23.649661,"eighty":-19.608912,"marketCap":620467774},{"date":"2026-02-20","current":4.021727,"twenty":-38.923318,"median":-23.601935,"eighty":-19.561129,"marketCap":612231476},{"date":"2026-02-27","current":4.256177,"twenty":-38.673097,"median":-23.492961,"eighty":-19.508534,"marketCap":647922100},{"date":"2026-03-06","current":4.664962,"twenty":-38.60711,"median":-23.396809,"eighty":-19.489511,"marketCap":710151906},{"date":"2026-03-13","current":3.826831,"twenty":-38.317356,"median":-23.305813,"eighty":-19.445457,"marketCap":665309840},{"date":"2026-03-20","current":3.358288,"twenty":-37.997629,"median":-23.223191,"eighty":-19.406656,"marketCap":583851876},{"date":"2026-03-25","current":3.158738,"twenty":-37.803912,"median":-23.161363,"eighty":-19.358818,"marketCap":549159228}],"updateTime":1774557912489},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PD\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1107419902","title":"PagerDuty- 11月22日，Owen Howard Wilson 通知其计划在公司任命继任者后退休，担任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1107419902","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107419902?lang=zh_cn&edition=fundamental","pubTime":"2025-11-26 05:13","pubTimestamp":1764105189,"startTime":"0","endTime":"0","summary":"PagerDuty- 11月22日，Owen Howard Wilson 通知其计划在公司任命继任者后退休，担任首席财务官","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","PD","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2584618171","title":"复星医药(600196.SH)：斯鲁利单抗纳入突破性治疗药物程序 全球范围内尚无靶向PD-1的单抗药品获批用于胃癌新辅助/辅助治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2584618171","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584618171?lang=zh_cn&edition=fundamental","pubTime":"2025-11-20 16:57","pubTimestamp":1763629023,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 复星医药(600196.SH)发布公告，根据国家药品监督管理局(以下简称“国家药监局”)药品审评中心公示信息，公司控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司自主研发的斯鲁利单抗注射液(中国境内1商品名：汉斯状®;以下简称“该药品”)用于联合化疗新辅助/辅助治疗胃癌(GCneo)已被纳入突破性治疗药物程序。该药品为集团自主研发的创新型抗 PD-1 单抗。截至本公告日期，全球范围内尚无靶向PD-1的单克隆抗体药品获批用于胃癌新辅助/辅助治疗。根据IQVIA MIDAS™最新数据，2024年，靶向PD-1的单克隆抗体药品于全球的销售额约为457.04亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600196","BK1191","BK0188","02196","BK0012","BK1515","LU1169589451.USD","BK0196","BK0175","PD","BK4023","BK0183","BK0028","BK0096","BK0239","LU1169590202.USD","BK1593","BK0060","BK0187"],"gpt_icon":0},{"id":"2584818419","title":"招商证券：首予三生制药（01530）“强烈推荐”评级 PD-1/VEGF双抗引领价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2584818419","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584818419?lang=zh_cn&edition=fundamental","pubTime":"2025-11-20 16:32","pubTimestamp":1763627548,"startTime":"0","endTime":"0","summary":"三生制药与辉瑞达成重磅授权协议，将SSGJ-707的全球权益授予辉瑞，辉瑞将支付14亿美元前端付款+48亿美元里程碑付款+1亿美元股份认购，创国产PD-(L)1/VEGF双抗BD纪录","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20251120/20251120163345_97955.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251120/20251120163345_97955.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06099","01530","PD"],"gpt_icon":0},{"id":"2584984363","title":"泽璟制药(688266.SH)：注射用ZG006与PD-1/PD-L1免疫检查点抑制剂及化疗(依托泊苷/卡铂)联用获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2584984363","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584984363?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 15:50","pubTimestamp":1763452203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泽璟制药 发布公告，公司于近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，注射用ZG006与PD-1/PD-L1免疫检查点抑制剂及化疗联合用于小细胞肺癌的临床试验获得批准。ZG006 是一种针对两个不同 DLL3 表位及CD3的三特异性T细胞衔接器。临床前研究结果显示，ZG006在小鼠肿瘤模型上具有显著的肿瘤抑制作用，可以导致显著比例的小鼠肿瘤完全消退，说明ZG006 具有强效的肿瘤杀伤作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1169589451.USD","LU1169590202.USD","BK4023","688266","BK0239","PD"],"gpt_icon":0},{"id":"2581038400","title":"复宏汉霖PD-L1 ADC肺癌新药发布关键数据，CEO朱俊：定位PD-1 联用的super ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2581038400","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581038400?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 10:36","pubTimestamp":1762396614,"startTime":"0","endTime":"0","summary":"近日，HLX43肺癌关键数据更新发布，首次合并NSCLC II期国际多中心临床研究结果，全球临床价值持续验证。他表示，复宏汉霖至少会开8个III期临床项目，预计会包括两个一线，四个二线，以及两个三线，而这8个III期临床都会集中在肺癌。业内认为，复宏汉霖估值上行的关键在于其自研PD-L1抗体偶联药物HLX43的全球潜力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1762338933079134283","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU1169590202.USD","BK4023","BK4080","PD","LU1169589451.USD","BK1161","BK4231","02696","ADC"],"gpt_icon":1},{"id":"2581779683","title":"PD-L1 ADC肺癌数据积极 复宏汉霖HLX43迎关键节点与资金考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779683","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581779683?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 22:31","pubTimestamp":1762353115,"startTime":"0","endTime":"0","summary":"在近日举行的“2025国际肺癌前沿及创新论坛”上，复宏汉霖更新了HLX43在非小细胞肺癌（NSCLC）研究领域的关键数据。研究数据显示，不论是在鳞状还是非鳞状NSCLC，无论EGFR突变状态、是否伴有脑转移或PD-L1表达水平如何，HLX43均观察到疗效信号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053556160251.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053556160251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1169590202.USD","LU1169589451.USD","BK4080","PD","BK4231","ADC","02696","BK1161","BK4023"],"gpt_icon":0},{"id":"2580227234","title":"基石药业-B(02616)宣布CS2009(PD-1/VEGF/CTLA-4三特异性抗体)Ⅱ期临床试验联合疗法IND在中国获批，深入探索三抗治疗潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2580227234","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580227234?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 08:05","pubTimestamp":1762214718,"startTime":"0","endTime":"0","summary":"智通财经APP讯，基石药业-B 发布公告，该公司今日宣布CS2009联合疗法用于晚期实体瘤的Ⅱ 期新药临床试验申请获中国国家药品监督管理局批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PD","LU1169590202.USD","BK1161","BK4023","02616","LU1169589451.USD","BK1574"],"gpt_icon":0},{"id":"2580966482","title":"三生国健(688336.SH)：辉瑞在某网站上登记PD-1/VEGF双抗PF-08634404(SSGJ-707)的两项全球III期临床试验其最终付款尚存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2580966482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580966482?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 18:25","pubTimestamp":1762165505,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生国健 发布股价异动公告称，公司及三生制药和沈阳三生共同授予被许可方辉瑞公司在许可区域及领域的独家开发、生产和商业化许可产品707项目的权利。《许可协议》于2025年7月24日正式生效。2025年10月30日，辉瑞在ClinicalTrials.gov网站上登记了PD-1/VEGF双抗PF-08634404的两项全球III期临床试验。鉴于《许可协议》中所约定的里程碑付款需要满足一系列特定条件，其最终付款尚存在不确定性，敬请广大投资者注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4023","LU0868494617.USD","SG9999002224.SGD","LU0289739699.SGD","PD","LU0306807586.USD","LU1023059063.AUD","LU1066053197.SGD","BK0239","IE00B19Z3B42.SGD","LU1057294990.SGD","LU1894683264.USD","LU1894683348.USD","LU1169589451.USD","LU0170899867.USD","BK4534","SG9999003800.SGD","BK4134","LU0306806265.USD","SGXZ57979304.SGD","SG9999001176.USD","LU0058720904.USD","IE000M9KFDE8.USD","LU0122379950.USD","III","BK4568","LU0225284248.USD","LU0225771236.USD","LU0234572021.USD","LU0456855351.SGD","688336","LU0985481810.HKD","BK4585","BK4007","SG9999002232.USD","LU1066051498.USD","SG9999001176.SGD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999013999.USD","BK4581","LU1169590202.USD","BK4533","LU0321505439.SGD","LU0321505868.SGD","LU1883839398.USD","BK4550","BK4592","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2580887230","title":"和誉-B(02256)完成口服小分子PD-L1抑制剂ABSK043联合戈来雷塞治疗NSCLC II期临床首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2580887230","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580887230?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 08:13","pubTimestamp":1762128819,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B 发布公告，2025年11月3日，和誉医药宣布，其口服小分子PD-L1抑制剂ABSK043与上海艾力斯医药科技股份有限公司(艾力斯) KRAS G12C抑制剂戈来雷塞联合用于治疗携带KRAS G12C突变的非小细胞肺癌的II期临床研究已完成首例患者给药。本项开放标签II期临床研究，旨在评估ABSK043联合戈来雷塞治疗携带KRAS G12C突变的局部晚期或转移性NSCLC患者的安全性、耐受性及有效性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1169589451.USD","PD","02256","BK1161","LU2488822045.USD","BK4023","LU1169590202.USD"],"gpt_icon":0},{"id":"2580140724","title":"PD-1 plus 全景扫描：从经典双免到多维进击","url":"https://stock-news.laohu8.com/highlight/detail?id=2580140724","media":"丁香园肿瘤时间","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580140724?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 20:20","pubTimestamp":1761913253,"startTime":"0","endTime":"0","summary":"全球药企都在布局 PD-1 plus，思路繁多，到底哪条路才是最正确的？例如，作为免疫治疗的开创者，百时美施贵宝就向我们展现了 PD-1 plus 探索的多样性。双免组合“历久弥新”基于百时美施贵宝的实际行动，不难得出一个结论：在 PD-1 plus 的探索中，证据丰富的成熟组合，仍是不容忽视的存在。百时美施贵宝很早就开始探索差异化的 PD-1 plus 策略，双免  O+Y  是全球有史以来第一个双重免疫检查点抑制剂组合，从 2015 年开始登场，至今已经在全球获批用于 7 个瘤种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031210933a6d8fd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031210933a6d8fd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505868.SGD","BK4023","BK4559","LU1074936037.SGD","IE00BSNM7G36.USD","LU2125154935.USD","BK4007","IE0009355771.USD","LU1989771016.USD","IE0002141913.USD","LU0882574055.USD","LU0225284248.USD","LU0114720955.EUR","LU0985481810.HKD","LU1032466523.USD","LU1868836914.USD","LU1670711040.USD","LU1585245621.USD","BK4534","LU1291159041.SGD","LU2242652126.USD","LU0306806265.USD","LU1323610961.USD","BK4581","LU1261432733.SGD","LU2242646821.SGD","LU1169589451.USD","LU0868494617.USD","BK4532","BK4585","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU2133065610.SGD","LU2125154778.USD","LU1169590202.USD","LU0321505439.SGD","LU0237698245.USD","LU1430594728.SGD","BK4588","IE00B2B36J28.USD","LU1868837300.USD","LU1868837136.USD","PD","LU1670710661.SGD","LU1093756325.SGD","LU1868836757.USD","BMY","LU0225771236.USD","IE00BJJMRZ35.SGD","LU1093756168.USD"],"gpt_icon":0},{"id":"2578572996","title":"默沙东PD-1+ADC杀疯了","url":"https://stock-news.laohu8.com/highlight/detail?id=2578572996","media":"氨基观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578572996?lang=zh_cn&edition=fundamental","pubTime":"2025-10-24 19:55","pubTimestamp":1761306933,"startTime":"0","endTime":"0","summary":"在这种背景下，默沙东率先探索IO+ADC协同路径。/ 02 /IO+ADC领头羊在PD-1+ADC这个赛道上，默沙东绝对是领头羊。默沙东此前在ASCO上也明确表示，将重点布局K药+ADC组合，以应对专利到期带来的市场压力。PD-1抑制剂主要激活免疫反应，但并非所有患者都敏感；而ADC可直接杀伤肿瘤细胞，同时释放抗原，进一步增强免疫应答。目前默沙东拥有业内最大的免疫肿瘤临床研究项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024200637a472b40c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024200637a472b40c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","LU2023250504.SGD","LU1169590202.USD","LU0211331839.USD","LU1037948897.HKD","LU1066051225.USD","LU0320765489.SGD","LU1069347547.HKD","LU1917777945.USD","LU0965509010.AUD","IE00B4R5TH58.HKD","LU1934455194.USD","SG9999015341.SGD","LU1061106388.HKD","MRK","LU1035773651.USD","BK4007","SG9999013999.USD","BK4550","BK4023","LU1093756168.USD","IE00BFTCPJ56.SGD","PD","LU0122379950.USD","LU1291159041.SGD","IE0009355771.USD","BK4534","LU2361044949.HKD","LU0070302665.USD","IE00BLSP4239.USD","LU0203345920.USD","LU0265550946.USD","LU2361045086.USD","LU2468319806.SGD","LU1066053197.SGD","LU1037948541.HKD","ADC","LU0985320562.USD","IE000M9KFDE8.USD","LU2461242641.AUD","SG9999002224.SGD","LU0861579265.USD","SG9999014575.USD","SG9999002232.USD","LU1941712348.USD","SG9999014567.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4516"],"gpt_icon":0},{"id":"2577367573","title":"PD-(L)1/VEGF赛道攻坚，依沃西冲击首个海外适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2577367573","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577367573?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 11:58","pubTimestamp":1761105514,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明当地时间10月20日，SummitTherapeutics（纳斯达克股票代码：SMMT）在2025年三季度财报中宣布，将于2025年第四季度向美国食品药品监督管理局（FDA）提交依沃西单抗联合化疗的生物制品许可申请（BLA），用于治疗经第三代EGFR-TKI治疗进展的EGFR突变非鳞状非小细胞肺癌（NSCLC）患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510223540978275.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510223540978275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1169589451.USD","BK4023","BK4585","LU0210528500.USD","PD","BK4588","LU0053666078.USD","LU1169590202.USD","LU2487616109.SGD","L","BK4107"],"gpt_icon":0},{"id":"2577681314","title":"【券商聚焦】交银国际维持康方生物(09926)买入评级 指依沃西较PD-1显著提升一线肺鳞癌PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2577681314","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577681314?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 09:06","pubTimestamp":1761008790,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，康方生物 在ESMO大会上公布了HARMONi-6研究的首次PFS分析结果。关键亚组分析显示，依沃西在PD-L1低表达人群中显示长拖尾效应。非头对头比较显示，依沃西中位PFS数值明显好于其他PD-1单靶药物，且相较PD-1的PFS改善绝对值已超过PD-1相较传统化疗的改善程度。依沃西新适应症上市申请已于2025年7月获CDE受理。该机构认为，依沃西最新临床数据已再次验证其相对现有PD-1标准治疗的显著疗效优势，彰显其成长为下一代 I/O 基石产品的潜力。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1968146","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","09926","PFS"],"gpt_icon":0},{"id":"2576000514","title":"复宏汉霖PD-L1 ADC HLX43获美国FDA孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2576000514","media":"南方财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576000514?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 08:47","pubTimestamp":1760921250,"startTime":"0","endTime":"0","summary":"南方财经10月20日电，复宏汉霖宣布，公司创新型程序性死亡-配体1（PD-L1）抗体偶联药物（ADC）注射用HLX43已获得美国食品药品监督管理局（FDA）授予的孤儿药资格认定（OrphanDrugDesignation,ODD），用于胸腺上皮肿瘤（ThymicEpithelialTumors，TETs）的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510203538123857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4231","02696","ADC","BK1161","LU1169589451.USD","PD","LU1169590202.USD","BK4080","BK4023"],"gpt_icon":0},{"id":"2575442735","title":"港股异动 | 基石药业-B(02616)涨超3% 将于ESMO大会上公布PD-1/VEGF/CTLA-4三抗I期剂量递增临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2575442735","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575442735?lang=zh_cn&edition=fundamental","pubTime":"2025-10-13 09:40","pubTimestamp":1760319650,"startTime":"0","endTime":"0","summary":"消息面上，基石药业-B发布公告，2025年欧洲肿瘤内科学会年会即将于2025年10月17日至21日在德国柏林举行。基石药业核心临床管线CS2009进行中的 I期剂量递增临床数据摘要和CS5001进行中的Ib期临床研究设计摘要目前已在 ESMO官网公布。在即将正式召开的ESMO大会上，基石药业将以壁报形式展示CS2009在约70例晚期实体瘤患者中的I期剂量递增临床研究初步数据，这也将是目前已知全球首个关于PD-1/VEGF/CTLA-4三特异性抗体的临床数据发表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02616","BK1161","YANG","BK4614","LU1169590202.USD","BK1574","PD","LU1169589451.USD","BK4023"],"gpt_icon":1},{"id":"2575444962","title":"基石药业-B(02616)将公布PD-1/VEGF/CTLA-4三抗I期剂量递增临床数据和ROR1 ADC最新研究设计","url":"https://stock-news.laohu8.com/highlight/detail?id=2575444962","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575444962?lang=zh_cn&edition=fundamental","pubTime":"2025-10-13 08:08","pubTimestamp":1760314120,"startTime":"0","endTime":"0","summary":"智通财经APP讯，基石药业-B 发布公告，2025年欧洲肿瘤内科学会年会即将于2025年10月17日至21日在德国柏林举行。基石药业核心临床管线CS2009进行中的 I期剂量递增临床数据摘要和CS5001进行中的Ib期临床研究设计摘要目前已在 ESMO官网公布。在即将正式召开的ESMO大会上，基石药业将以壁报形式展示CS2009在约70例晚期实体瘤患者中的I期剂量递增临床研究初步数据，这也将是目前已知全球首个关于PD-1/VEGF/CTLA-4三特异性抗体的临床数据发表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","ADC","BK1161","LU1169589451.USD","02616","BK4231","LU1169590202.USD","PD","BK1574","BK4023"],"gpt_icon":0},{"id":"2574133766","title":"山西证券：首予三生制药(01530)“买入-B”评级 PD-1/VEGF双抗是潜在的肿瘤基石药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2574133766","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574133766?lang=zh_cn&edition=fundamental","pubTime":"2025-10-09 15:14","pubTimestamp":1759994066,"startTime":"0","endTime":"0","summary":"公司有30项在研产品，核心管线PD-1/VEGF双抗SSGJ-707全球权益已授权给辉瑞制药，首付款为15亿美元，潜在里程碑付款48亿美元，以及双位数销售梯度分成。山西证券主要观点如下：SSGJ-707是潜在的肿瘤基石药物PD-1疗法是肿瘤治疗的基础方案之一，预计PD-1单抗全球市场在2029年达990亿美元。PD-1/VEGF双抗对抗血管和免疫检查点协同抑制，具比PD-1单抗更优的疗效潜力。SSGJ-707是四价结构的PD-1/VEGF双抗，VEGF存在下对PD-1结合亲和力增强100倍，独特的IgG4 Fc设计有望降低免疫副作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01530","002500","PD"],"gpt_icon":0},{"id":"2574187727","title":"天风证券：维持和誉-B(02256)“买入”评级 口服PD-L1与多药联用布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2574187727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574187727?lang=zh_cn&edition=fundamental","pubTime":"2025-10-09 14:09","pubTimestamp":1759990163,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，天风证券发布研报称，维持和誉-B“买入”评级，预计公司2025-2027年的营业收入分别为6.30亿元、6.85亿元和6.37亿元，归母净利润为0.45亿元、0.70亿元和1.02亿元。公司的PD-L1小分子抑制剂ABSK043联合KRASG12C抑制剂戈来雷塞片开展联合用药治疗KRASG12C突变的NSCLC的临床研究申请获CDE批准。此前，公司已经与艾力斯就联合用药达成了合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601162","02256","PD"],"gpt_icon":0},{"id":"2574903384","title":"Pagerduty, Inc.盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574903384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574903384?lang=zh_cn&edition=fundamental","pubTime":"2025-10-09 00:13","pubTimestamp":1759940032,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日00时13分，Pagerduty, Inc.股票出现异动，股价急速拉升5.05%。Pagerduty, Inc.股票所在的软件服务行业中，整体涨幅为0.41%。其相关个股中，Connexa Sports Technologies Inc.、Smith Micro Software, Inc.、Figma, Inc.涨幅较大，Connexa Sports Technologies Inc.、一品威客、Signing Day Sports, Inc.较为活跃，换手率分别为4837.41%、330.11%、46.66%，振幅较大的相关个股有Connexa Sports Technologies Inc.、一品威客、Triller Group Inc C/Wts 15/03/2027 ，振幅分别为126.00%、35.36%、33.96%。Pagerduty, Inc.公司简介：PagerDuty 是一个数字运营管理平台，可为现代数字业务管理紧急和任务关键型工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009001353a6b0ee03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009001353a6b0ee03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PD","BK4023","LU1169590202.USD","LU1169589451.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}